Opaleye Management reports acquisition of $136,177.7221 in Grace Therapeutics common shares
GRCE•Opaleye Management purchased 71,065 Grace Therapeutics common shares for a total of $136,177.7221. Its indirect holdings through Opaleye, L.P. rose to 2,944,354 shares.
1. Share purchases
Opaleye Management, a 10% owner of Grace Therapeutics, purchased 71,065 common shares. The purchases comprised 11,233 shares at $1.9349, 23,485 at $1.9453 and 36,347 at $1.8917; indirect holdings through Opaleye, L.P. rose to 2,944,354 shares.
